In Other News

• Rapid Urine Test Speeds Antibiotic Selection for UTIs

• AI-Based Pathology Model Guides Chemotherapy Decisions in Breast Cancer

• Lunit and CellCarta Collaborate to Expand AI Pathology in CDx Development

• New Molecular Test Boosts Accuracy of Bile Duct Cancer Diagnosis

• Adaptive PCR Platform Improves Consistency in Small-Batch NGS Workflows

• New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia

• Researchers Identify Survival Pathway Undermining Targeted Cancer Drugs

• Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection

• Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection

• Rapid Biosensor Detects Drug Sensitivity in Breast Tumors

• Study Reveals Diagnostic and Therapeutic Target in Rare Pancreatic Tumors

• FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

• WHO Endorses Rapid Point-of-Care Testing to Improve TB Detection

• New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs

• First IVDR‑Certified IGH Clonality Assay Supports Diagnosis of B-Cell Malignancies

• Rapid Biosensor Detects Drug Sensitivity in Breast Tumors

• Large-Scale Study Maps DNA Damage Signatures Across Multiple Cancers

• New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs

• Study Shows Dual Biomarkers Improve Accuracy of Alzheimer’s Detection

• First IVDR‑Certified IGH Clonality Assay Supports Diagnosis of B-Cell Malignancies

• Large-Scale Study Maps DNA Damage Signatures Across Multiple Cancers

• Portable Test Uses CRISPR to Rapidly Identify STIs and Resistance Markers

• Plasma ctDNA Testing Predicts Breast Cancer Recurrence After Neoadjuvant Therapy